EDMONTON, ALBERTA--(CCNMatthews - Dec. 23, 2005) - - Trading on the AMEX to begin on December 23, 2005 under the symbol REX - ViRexx Medical Corp. (TSX:VIR) (AMEX:REX) a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, announced today that it has cleared all comments from the U.S. Securities and Exchange Commission regarding its Form 20-F registration document and has received approval from the American Stock Exchange (“AMEX”) for the listing of ViRexx’s common shares on the AMEX. Trading on the AMEX is expected to commence today, December 23, 2005, at the opening of market under the symbol “REX”. ViRexx’s common shares will continue to trade on the Toronto Stock Exchange under the symbol “VIR”.
